Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, describes the structure, aims, and results of the MOMENTUM study (NCT04173494), which aims to compare the efficacy of momelotinib to danazol in treating myelofibrosis (MF), highlighting the place of momelotinib in the treatment algorithm of MF. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.